![Direct healthcare costs and resource consumption after acute coronary syndrome: a real-life analysis of an Italian subpopulation - Daniela P Roggeri, Alessandro Roggeri, Elisa Rossi, Elisa Cinconze, Marisa De Rosa, Aldo P Direct healthcare costs and resource consumption after acute coronary syndrome: a real-life analysis of an Italian subpopulation - Daniela P Roggeri, Alessandro Roggeri, Elisa Rossi, Elisa Cinconze, Marisa De Rosa, Aldo P](https://journals.sagepub.com/cms/10.1177/2047487313483608/asset/images/large/10.1177_2047487313483608-fig2.jpeg)
Direct healthcare costs and resource consumption after acute coronary syndrome: a real-life analysis of an Italian subpopulation - Daniela P Roggeri, Alessandro Roggeri, Elisa Rossi, Elisa Cinconze, Marisa De Rosa, Aldo P
Optimal threshold of adherence to lipid lowering drugs in predicting acute coronary syndrome, stroke, or mortality: A cohort study | PLOS ONE
![From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary Syndromes: JACC State-of-the-Art Review - ScienceDirect From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary Syndromes: JACC State-of-the-Art Review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109719361601-fx1.jpg)
From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary Syndromes: JACC State-of-the-Art Review - ScienceDirect
![Treatment of Acute Coronary Syndromes in the Elderly and in Patients With Comorbidities | Revista Española de Cardiología Treatment of Acute Coronary Syndromes in the Elderly and in Patients With Comorbidities | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1885585714001388:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w99KBUZDJuFlLjKo5clFAJaBzV3lXurjotj++nFCAYF1NQLWG100M7OZEJTign/qk7dP8X9Iqeo6SMHHq7IFTRTkYqOZAvsl3TF1m/7SneaWQ3W7DCbYoyl40hWVKXuEFSoIn9OSbFZqbO6MIMsiR5d3hhXPQ//3ltlWJTzLbiyexxedTmyRoQ/ARGQdcfzltf6Z+3Fl9RGd9GRN0Dbueyi0xQJa/voZkXxEPJX67Jdf9sYIj92NUvlYlw+6v3n/potjZ648WMwSp63nxY94yTRs=)
Treatment of Acute Coronary Syndromes in the Elderly and in Patients With Comorbidities | Revista Española de Cardiología
![Antithrombotic Therapy in Acute Coronary Syndrome: Striking a Happy Medium | Revista Española de Cardiología Antithrombotic Therapy in Acute Coronary Syndrome: Striking a Happy Medium | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1885585718301099:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w99KBUZDJuFlLjKo5clFAJaBzV3lXurjotj++nFCAYF1NAWe0Nuoe8XVWAXbQijr7SyDtbVmpgu+aeBqWe2fQJRgeaUcCTVwupOfJlYsy9RUzcVmDNH+ZgplQk8tIsS9x5aXzlEJ0H6i2Bmmn4G48PNkmnpzYD1ULtLUsV8V77PhIA1wWUYUeDqIlRiH01jwni5dVFvusL9ny2d8wDudkeU5SskBdYRwTKNWCvTXSNs8okwrQvXRHla36iCAC8jU7xNVoVTE2kYd3v70XwRVEso8=)
Antithrombotic Therapy in Acute Coronary Syndrome: Striking a Happy Medium | Revista Española de Cardiología
Nonclinical Safety Signals in PharmaPendium Improve the Predictability of Human Drug-Induced Liver Injury | Chemical Research in Toxicology
A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions | Journal of Medicinal Chemistry
![Medications used in 829 patients diagnosed with acute coronary syndrome... | Download Scientific Diagram Medications used in 829 patients diagnosed with acute coronary syndrome... | Download Scientific Diagram](https://www.researchgate.net/publication/328595651/figure/tbl1/AS:871959676080128@1584902795552/Medications-used-in-829-patients-diagnosed-with-acute-coronary-syndrome-following.png)
Medications used in 829 patients diagnosed with acute coronary syndrome... | Download Scientific Diagram
![Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial - The Lancet Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/2095457388/2077627720/gr1.gif)
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial - The Lancet
![Many shades of grey: seeking the optimal medical therapy of acute coronary syndrome in older people - Paratz - 2017 - Journal of Pharmacy Practice and Research - Wiley Online Library Many shades of grey: seeking the optimal medical therapy of acute coronary syndrome in older people - Paratz - 2017 - Journal of Pharmacy Practice and Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9d4cc43f-e887-42fb-8cc6-8592c4364fe5/jppr1365-fig-0001-m.jpg)